N,N-Diethyl-2-((5-methoxybenzo[d]oxazol-2-yl)thio)ethanamine

ADVERTISEMENT

Identification

Molecular formula
C14H20N2O2S
CAS Number
NA
IUPAC Name
N,N-diethyl-2-[(5-methoxy-1,3-benzoxazol-2-yl)sulfanyl]ethanamine
Molecular Weight
278.39g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2000g/cm3
Interesting facts

Exploring N,N-Diethyl-2-[(5-methoxy-1,3-benzoxazol-2-yl)sulfanyl]ethanamine

N,N-Diethyl-2-[(5-methoxy-1,3-benzoxazol-2-yl)sulfanyl]ethanamine is a fascinating compound that showcases the unique intersection of organic chemistry and medicinal applications. Known for its complex molecular structure, this compound belongs to the class of aminothiols and is particularly intriguing due to the incorporation of both sulfur and nitrogen heteroatoms which amplifies its chemical reactivity.

Key Features of the Compound:

  • Pharmacological Interest: This compound has attracted attention in the field of medicinal chemistry for its potential therapeutic applications. Its unique structure raises possibilities for the development of novel drugs, especially in the realm of neuropharmacology.
  • Heterocyclic Structure: The presence of the benzoxazole moiety contributes to the compound's stability and interacts favorably with biological targets. Heterocycles are often crucial in drug design as they can mimic the structure of naturally occurring compounds.
  • Sulfur’s Role: The thiol group can have significant implications in biological systems, such as in redox reactions and interactions with metal ions, potentially leading to antioxidant properties.

As emphasized by prominent chemists, "Understanding the subtleties of compound interactions at a molecular level can unveil pathways to innovative solutions in medicine." With its intriguing chemistry and biological relevance, N,N-Diethyl-2-[(5-methoxy-1,3-benzoxazol-2-yl)sulfanyl]ethanamine not only expands the scope of chemical investigations but aligns itself with modern approaches to drug discovery.

In synthesis, compounds like these represent a promising frontier in developing therapeutics that can address increasingly complex health challenges.

ADVERTISEMENT